NCT07123909 Studies on Adsorption International Learning Initiative Global
| NCT ID | NCT07123909 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Botkin Hospital |
| Condition | CKD (Chronic Kidney Disease) Stage 5D |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2025-06-01 |
| Primary Completion | 2026-03-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2025-06-01 with a primary completion date of 2026-03-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Use of sorption technologies in patients undergoing maintenance hemodialysis with inflammatory syndrome and clinical manifestations of uremia
Eligibility Criteria
Inclusion Criteria: 1. Adequate dialysis defined by a KT/V index ≥ 1.4 2. No active inflammatory process or infection 3. Age ≥ 18 years 4. Receiving standard hemodialysis regimen three times weekly, at least 4 hours per session 5. Participants with elevated interleukin-6 (IL-6) and/or C-reactive protein (CRP) levels exceeding local laboratory reference values Exclusion Criteria: 1. Current use of steroids or immunosuppressive therapy 2. History of kidney transplantation 3. Diagnosis of cancer 4. Pregnancy
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07123909 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying CKD (Chronic Kidney Disease) Stage 5D. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07123909 currently recruiting?
Yes, NCT07123909 is actively recruiting participants. Contact the research team at shutov_e_v@mail.ru for enrollment information.
Where is the NCT07123909 trial being conducted?
This trial is being conducted at Moscow, Russia.
Who is sponsoring the NCT07123909 clinical trial?
NCT07123909 is sponsored by Botkin Hospital. The trial plans to enroll 60 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.